DocWire News Editors

DocwireNews

Scientists are just beginning to explore the effects of COVID-19 (SARS-CoV-2) on specific populations of patients with chronic disease. At the 62nd ASH Annual Meeting &amp; Exposition, a group of researchers presented a study of COVID-19 in patients with myelodysplastic syndromes (MDS).The researchers performed a prospective case series study of all patients seen in an MDS clinic at a large academic medical center in New York City. The researchers included patients seen between March 12, 2020, and May 7, 2020. Lead author Jonathan Feld, MD, of the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, N.Y., and coauthors said their study is &ldquo;the first reported large case series regarding the risks of developing COVID-19 and its effects at an MDS clinic in the initial U.S. epicenter of the pandemic.&rdquo;Overall, the clinic saw 85 patients, and 23 (27%) tested positive for COVID-19. Of those, 11 (48%) were hospitalized and four (17%) were asymptomatic. Nine of the 23 COVID-19-positive patients died (39.1%, or 10.6% of the overall cohort). Bust most recovered and resumed MDS therapy.The presenters said the rate they found compares to a previously published mortality rate of 16% in a broader population of patients with cancer and COVID-19. They added that the higher mortality rate they found in MDS is likely associated with the patients&rsquo; comorbidities (including cardiac disease, hypertension, diabetes, and dementia) and older age (median, 75 years).The most common symptoms in patients with MDS and COVID-19 were:<ul>
<li>Upper respiratory symptoms (n=15)</li>
<li>Fever (n=14)</li>
<li>Acute respiratory distress syndrome and pneumonia (n=4)</li>
</ul>They received the following treatments most often:<ul>
<li>Hydroxychloroquine (n=4)</li>
<li>Steroids (n=3)</li>
<li>Azithromycin (n=2)</li>
</ul>Among other noteworthy findings, they said, COVID-19 antibodies were found in many the patients tested, showing that patients with MDS &ldquo;can mount a humoral response. &hellip; However, protecting MDS patients from COVID-19 infection must be a primary overall therapeutic approach until there are more effective COVID-19 treatment strategies,&rdquo; the researchers stressed.

Jordana Jampel

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Eric Bergson, MD

Rob Dillard

The Role of Multidisciplinary Care in Head and Neck Cancer

Head and Neck Cancer

Sara Nunnery, MD, MSCI

Trastuzumab Deruxtecan in HER2-Low Breast Cancer: Who’s the Right Patient?

HER2 Breast Cancer

Latest News

Study Explores Outcomes of Patients with MDS and COVID-19 in Pandemic Epicenter

ASH Annual Meeting 2020

Scientists are just beginning to explore the effects of COVID-19 (SARS-CoV-2) on specific populations of patients with chronic disease. At the 62nd ASH Annual Meeting &amp; ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe